Art Therapy for Chronic Pain and Opioid Use Disorder
Trial Summary
What is the purpose of this trial?
The primary purpose of this study is to assess the acceptability of self-directed art making for people with chronic pain and OUD/opioid misuse, or to state it another way, whether people with chronic pain and OUD/opioid misuse will realistically do this artistic practice on their own. A secondary question of this study is to explore whether doing this art practice can help minimize pain during the artistic process, lessen depression and anxiety, and improve feelings of social connection.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatment, especially since the study focuses on art therapy rather than medication changes.
What data supports the effectiveness of the treatment Self-Driven Repetitive Artmaking, Art Therapy, Self-Directed Art Making, Repetitive Artmaking Practice for chronic pain and opioid use disorder?
The research suggests that arts-based interventions, like music, can help reduce pain and the need for pain medication, and improve readiness for substance use disorder treatment. Although specific studies on art therapy for chronic pain and opioid use disorder are limited, the positive effects of similar arts-based strategies indicate potential benefits.12345
Is art therapy safe for managing chronic pain and opioid use disorder?
The available evidence suggests that arts-based interventions, like music, are generally safe and may help reduce pain and improve motivation for treatment in people with substance use disorders. However, there is limited research specifically on art forms other than music, so more studies are needed to confirm their safety and effectiveness.13678
How is the treatment Self-Driven Repetitive Artmaking different from other treatments for chronic pain and opioid use disorder?
Research Team
Jenny Seham, PhD
Principal Investigator
Montefiore Medical Center
Eligibility Criteria
This trial is for individuals with chronic pain and opioid use disorder or opioid misuse. It's designed to see if they will engage in self-driven artmaking on their own as a potential therapeutic activity.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
In-Person Workshop
Participants attend a two-hour in-person workshop led by an Art Therapist to gather patient characteristic data and orient them to the use of art kits.
At-Home Artmaking
Participants use art kits at home up to four times over four months, completing pre- and post-surveys to assess pain, mood, and social connectivity.
Follow-up
Participants are monitored for safety and effectiveness after the artmaking intervention, including qualitative feedback sessions.
Treatment Details
Interventions
- Self-Driven Repetitive Artmaking (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor
Andrew D. Racine
Montefiore Medical Center
Chief Medical Officer since 1992
MD, PhD from New York University; Undergraduate degree from Harvard University
Philip O. Ozuah
Montefiore Medical Center
Chief Executive Officer since 2019
MD, PhD from New York University
National Institute on Drug Abuse (NIDA)
Collaborator
Dr. Nora Volkow
National Institute on Drug Abuse (NIDA)
Chief Executive Officer since 2003
MD from National Autonomous University of Mexico
Dr. Nora Volkow
National Institute on Drug Abuse (NIDA)
Chief Medical Officer since 2003
MD from National Autonomous University of Mexico